A new mild hyperthermia device to treat vascular involvement in cancer surgery
Open Access
- 12 September 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-14
Abstract
Surgical margin status in cancer surgery represents an important oncologic parameter affecting overall prognosis. The risk of disease recurrence is minimized and survival often prolonged if margin-negative resection can be accomplished during cancer surgery. Unfortunately, negative margins are not always surgically achievable due to tumor invasion into adjacent tissues or involvement of critical vasculature. Herein, we present a novel intra-operative device created to facilitate a uniform and mild heating profile to cause hyperthermic destruction of vessel-encasing tumors while safeguarding the encased vessel. We use pancreatic ductal adenocarcinoma as an in vitro and an in vivo cancer model for these studies as it is a representative model of a tumor that commonly involves major mesenteric vessels. In vitro data suggests that mild hyperthermia (41–46 °C for ten minutes) is an optimal thermal dose to induce high levels of cancer cell death, alter cancer cell’s proteomic profiles and eliminate cancer stem cells while preserving non-malignant cells. In vivo and in silico data supports the well-known phenomena of a vascular heat sink effect that causes high temperature differentials through tissues undergoing hyperthermia, however temperatures can be predicted and used as a tool for the surgeon to adjust thermal doses delivered for various tumor margins.Keywords
This publication has 50 references indexed in Scilit:
- Uncovering the role of p53 splice variants in human malignancy: a clinical perspectiveOncoTargets and Therapy, 2013
- Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft ModelPLOS ONE, 2012
- Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteriesJournal of Pediatric Surgery, 2011
- Role of Pancreatic Stellate Cells in Pancreatic Cancer MetastasisThe American Journal of Pathology, 2010
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor ProgressionCancer Research, 2008
- The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cellsJournal of Experimental Medicine, 2006
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006
- Desmoplastic Reaction in Pancreatic CancerPancreas, 2004
- Effect of Vessel Size on Creation of Hepatic Radiofrequency Lesions in PigsAmerican Journal of Roentgenology, 2002